Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
LC Sign delivers custom LED signage via a project-driven MaaS model. Our 20,000m² factory & 400+ team provide bespoke, high-precision branding solutions.
Read More -
DUBAI, United Arab Emirates, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) continues to move through its published roadmap as investor participation grows and development milestones...
Read More
-
Next steps entail discussions on a potential POC project for integrating Foresight’s terrain intelligence into Audi’s vehicle development program Ness Ziona, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE)...
-
Syntiant introduces two new package options for its NDP115 Neural Decision Processor.
-
Company Announcement Genmab to discontinue clinical development of acasunlimab following a portfolio reviewDecision reflects prioritization of higher‑impact opportunities across Genmab’s late‑stage...
-
New York City, NY, Dec. 29, 2025 (GLOBE NEWSWIRE) -- As payout delays and unclear promotions continue to challenge the global iGaming market, BitStarz is setting a new standard by streamlining...
-
WESTPORT, Conn., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today its consolidated...
-
The global thermoplastic polyimides market size is expected to grow from USD 795.39 million in 2026 to USD 1,926.61 million by 2035, growing at a CAGR of 9
-
Reduces Annual Cash Burn and Positions Company for AI-Driven Growth Miami, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI” or the “Company”), a global AI driven...
-
Peer-reviewed NC State study found Babesia in 24% of chronic fatigue patients, supporting further study of chronic babesiosis and ARAKODA® evaluation.
-
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the leader in Agentic Commerce and AI-powered customer engagement, today announced the launch of Revenue Pools by its wholly...
-
Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposureFDA denial of Sanofi’s tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec. ...